Literature DB >> 25757748

Striatal blood-brain barrier permeability in Parkinson's disease.

Madison T Gray1, John M Woulfe2.   

Abstract

In vivo studies have shown that blood-brain barrier (BBB) dysfunction is involved in the course of Parkinson's disease (PD). However, these have lacked either anatomic definition or the ability to recognize minute changes in BBB integrity. Here, using histologic markers of serum protein, iron, and erythrocyte extravasation, we have shown significantly increased permeability of the BBB in the postcommissural putamen of PD patients. The dense innervation of the striatum by PD-affected regions allows for exploitation of this permeability for therapeutic goals. These results are also discussed in the context of the retrograde trans-synaptic hypothesis of PD spread.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25757748      PMCID: PMC4420870          DOI: 10.1038/jcbfm.2015.32

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  16 in total

1.  Proteinase K-resistant alpha-synuclein is deposited in presynapses in human Lewy body disease and A53T alpha-synuclein transgenic mice.

Authors:  Kunikazu Tanji; Fumiaki Mori; Junsei Mimura; Ken Itoh; Akiyoshi Kakita; Hitoshi Takahashi; Koichi Wakabayashi
Journal:  Acta Neuropathol       Date:  2010-03-26       Impact factor: 17.088

2.  6-Hydroxydopamine-induced alterations in blood-brain barrier permeability.

Authors:  P M Carvey; C H Zhao; B Hendey; H Lum; J Trachtenberg; B S Desai; J Snyder; Y G Zhu; Z D Ling
Journal:  Eur J Neurosci       Date:  2005-09       Impact factor: 3.386

3.  Vascular endothelial growth factor is upregulated by L-dopa in the parkinsonian brain: implications for the development of dyskinesia.

Authors:  K Elisabet Ohlin; Veronica Francardo; Hanna S Lindgren; Stephanie E Sillivan; Sean S O'Sullivan; Andrew S Luksik; Fair M Vassoler; Andrew J Lees; Christine Konradi; M Angela Cenci
Journal:  Brain       Date:  2011-07-19       Impact factor: 13.501

Review 4.  The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia.

Authors:  Walter J Schulz-Schaeffer
Journal:  Acta Neuropathol       Date:  2010-06-20       Impact factor: 17.088

5.  Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease.

Authors:  Vanessa Brochard; Béhazine Combadière; Annick Prigent; Yasmina Laouar; Aline Perrin; Virginie Beray-Berthat; Olivia Bonduelle; Daniel Alvarez-Fischer; Jacques Callebert; Jean-Marie Launay; Charles Duyckaerts; Richard A Flavell; Etienne C Hirsch; Stéphane Hunot
Journal:  J Clin Invest       Date:  2008-12-22       Impact factor: 14.808

6.  Neuron-to-neuron transmission of α-synuclein fibrils through axonal transport.

Authors:  Eric C Freundt; Nate Maynard; Eileen K Clancy; Shyamali Roy; Luc Bousset; Yannick Sourigues; Markus Covert; Ronald Melki; Karla Kirkegaard; Michel Brahic
Journal:  Ann Neurol       Date:  2012-10       Impact factor: 10.422

7.  Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer's disease.

Authors:  Jesse D Sengillo; Ethan A Winkler; Corey T Walker; John S Sullivan; Mahlon Johnson; Berislav V Zlokovic
Journal:  Brain Pathol       Date:  2012-11-28       Impact factor: 6.508

8.  Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson's disease.

Authors:  Valerio Pisani; Alessandro Stefani; Mariangela Pierantozzi; Silvia Natoli; Paolo Stanzione; Diego Franciotta; Antonio Pisani
Journal:  J Neuroinflammation       Date:  2012-08-08       Impact factor: 8.322

9.  Cortical microhemorrhages cause local inflammation but do not trigger widespread dendrite degeneration.

Authors:  Nathanael L Rosidi; Joan Zhou; Sanket Pattanaik; Peng Wang; Weiyang Jin; Morgan Brophy; William L Olbricht; Nozomi Nishimura; Chris B Schaffer
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

10.  Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis.

Authors:  Ethan A Winkler; Jesse D Sengillo; John S Sullivan; Jenny S Henkel; Stanley H Appel; Berislav V Zlokovic
Journal:  Acta Neuropathol       Date:  2012-09-01       Impact factor: 17.088

View more
  108 in total

Review 1.  Microglial interactions with the neurovascular system in physiology and pathology.

Authors:  Xiaoliang Zhao; Ukpong B Eyo; Madhuvika Murugan; Long-Jun Wu
Journal:  Dev Neurobiol       Date:  2018-02-01       Impact factor: 3.964

Review 2.  Blood-brain barrier opening with focused ultrasound in experimental models of Parkinson's disease.

Authors:  Maria Eleni Karakatsani; Javier Blesa; Elisa Evgenia Konofagou
Journal:  Mov Disord       Date:  2019-07-30       Impact factor: 10.338

Review 3.  Defining Dysbiosis in Disorders of Movement and Motivation.

Authors:  Christopher T Fields; Timothy R Sampson; Annadora J Bruce-Keller; Drew D Kiraly; Elaine Y Hsiao; Geert J de Vries
Journal:  J Neurosci       Date:  2018-10-31       Impact factor: 6.167

Review 4.  Associations between atherosclerosis and neurological diseases, beyond ischemia-induced cerebral damage.

Authors:  Dannia Colín-Castelán; Silvio Zaina
Journal:  Rev Endocr Metab Disord       Date:  2019-03       Impact factor: 6.514

Review 5.  Metabolic Dysfunction in Parkinson's Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism.

Authors:  Annadurai Anandhan; Maria S Jacome; Shulei Lei; Pablo Hernandez-Franco; Aglaia Pappa; Mihalis I Panayiotidis; Robert Powers; Rodrigo Franco
Journal:  Brain Res Bull       Date:  2017-03-21       Impact factor: 4.077

6.  The 3D Brain Unit Network Model to Study Spatial Brain Drug Exposure under Healthy and Pathological Conditions.

Authors:  Esmée Vendel; Vivi Rottschäfer; Elizabeth C M de Lange
Journal:  Pharm Res       Date:  2020-07-09       Impact factor: 4.200

Review 7.  Microglia and astrocyte dysfunction in parkinson's disease.

Authors:  Tae-In Kam; Jared T Hinkle; Ted M Dawson; Valina L Dawson
Journal:  Neurobiol Dis       Date:  2020-07-28       Impact factor: 5.996

8.  Flow-metabolism dissociation in the pathogenesis of levodopa-induced dyskinesia.

Authors:  Vincent A Jourdain; Chris C Tang; Florian Holtbernd; Christian Dresel; Yoon Young Choi; Yilong Ma; Vijay Dhawan; David Eidelberg
Journal:  JCI Insight       Date:  2016-09-22

Review 9.  Nanomaterial-based blood-brain-barrier (BBB) crossing strategies.

Authors:  Jinbing Xie; Zheyu Shen; Yasutaka Anraku; Kazunori Kataoka; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2019-09-14       Impact factor: 12.479

Review 10.  Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders.

Authors:  Melanie D Sweeney; Abhay P Sagare; Berislav V Zlokovic
Journal:  Nat Rev Neurol       Date:  2018-01-29       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.